Regencell Bioscience Holdings Ltd Financial Flexibility Index
Regencell Bioscience Holdings Ltd financial flexibility index. Regencell Bioscience Holdings Ltd (RGC) has a Financial Flexibility Index of -1.44x as of March 2026. Free cash flow of $-2.59 Million (operating CF $-2.59 Million minus capex $2.00) represents -1% of total liabilities ($1.79 Million). See free cash flow generation of Regencell Bioscience Holdings Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Regencell Bioscience Holdings Ltd (2003–2025)
Financial flexibility index of Regencell Bioscience Holdings Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Regencell Bioscience Holdings Ltd across 23 annual periods. Check earnings quality score of Regencell Bioscience Holdings Ltd to evaluate the quality of earnings relative to operating cash generation.
Regencell Bioscience Holdings Ltd Financial Flexibility Index by Year (2003–2025)
Regencell Bioscience Holdings Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Regencell Bioscience Holdings Ltd. For the full cash flow conversion analysis, see how efficiently does Regencell Bioscience Holdings Ltd generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.31x | $-2.96 Million | $-3.11 Million | $895.31K | ▲ +81.8% |
| 2024 | -18.21x | $-4.00 Million | $-4.00 Million | $219.51K | ▼ -133.2% |
| 2023 | -7.81x | $-4.94 Million | $-4.96 Million | $632.32K | ▼ -63.2% |
| 2022 | -4.78x | $-4.49 Million | $-5.27 Million | $938.03K | ▼ -2603.7% |
| 2021 | -0.18x | $-767.31K | $-767.31K | $4.34 Million | ▲ +8.0% |
| 2020 | -0.19x | $-608.74K | $-726.57K | $3.16 Million | ▼ -46.6% |
| 2019 | -0.13x | $-273.15K | $-390.99K | $2.08 Million | ▼ -173.5% |
| 2018 | 0.18x | $660.30 Million | $409.90 Million | $3.70 Billion | ▼ -0.5% |
| 2017 | 0.18x | $625.40 Million | $410.50 Million | $3.48 Billion | ▲ +1.6% |
| 2016 | 0.18x | $620.10 Million | $434.40 Million | $3.51 Billion | ▲ +19.9% |
| 2015 | 0.15x | $505.90 Million | $349.10 Million | $3.43 Billion | ▲ +9.7% |
| 2014 | 0.13x | $459.00 Million | $346.90 Million | $3.42 Billion | ▼ -10.4% |
| 2013 | 0.15x | $435.80 Million | $346.60 Million | $2.91 Billion | ▼ -0.8% |
| 2012 | 0.15x | $440.30 Million | $353.10 Million | $2.91 Billion | ▲ +26.0% |
| 2011 | 0.12x | $357.80 Million | $259.40 Million | $2.98 Billion | ▼ -33.4% |
| 2010 | 0.18x | $519.60 Million | $410.80 Million | $2.88 Billion | ▲ +89.5% |
| 2009 | 0.10x | $270.00 Million | $270.00 Million | $2.84 Billion | ▼ -67.3% |
| 2008 | 0.29x | $800.00 Million | $800.00 Million | $2.75 Billion | ▲ +137.9% |
| 2007 | 0.12x | $304.00 Million | $304.00 Million | $2.49 Billion | ▼ -20.9% |
| 2006 | 0.15x | $386.00 Million | $386.00 Million | $2.50 Billion | ▼ -1.5% |
| 2005 | 0.16x | $387.00 Million | $387.00 Million | $2.47 Billion | ▼ -45.0% |
| 2004 | 0.28x | $476.00 Million | $476.00 Million | $1.67 Billion | ▼ -21.0% |
| 2003 | 0.36x | $373.00 Million | $373.00 Million | $1.04 Billion | — |